Our Partners


  • Andreas Rummelt Ph. D., Chairman

    • Over 25 years of senior leadership experience at Novartis. Senior positions included: 

      • Member of the Novartis Executive Committee 

      • Group Head Quality Assurance & Technical Operations, Novartis International 

      • CEO Sandoz (Generics Division of Novartis) 

      • Global Head Technical Operations, Novartis Pharma 

    • Member of the Boards of Directors of AstraZeneca, Alvogen and Xellia Pharmaceuticals

    • M.Sc. degree and Ph.D. in Pharmacy

  • Matthias Pohl M.Sc., Managing Partner

    • Over 25 years of senior leadership experience in the pharmaceutical industry. Senior positions included:

      • VP Global Quality Operations at CSL Behring

      • Global Head HSE and BCM at Novartis Pharma

      • Site Head of Novartis Pharma Stein

      • Head of Global Quality Assurance at Sandoz

    • Extensive experience Technical Operations, Quality, Health Safety and Environment, and Business Continuity Management

    • M.Sc. degree in Pharmacy

  • Marc Müller Ph.D., Partner

    • Over 20 years of healthcare practice experience at InterPharmaLink and McKinsey. Key fields of experience include: 

      • Corporate Development and M&A Advisory

      • Market Entry and Partnering Strategies

      • Manufacturing Network and Supply Chain Optimizations

      • Due Diligence and Operational Improvement Programs

    • Extensive experience in international project and program management and steering

    • M.Sc. degree in Engineering and Ph.D. in Economics

  • Eric Gorka M.Sc., Partner

    • Over 25 years of senior leadership experience in commercial operations at Sandoz. Senior positions included: 

      • Head Cluster Netherlands & Nordics at Sandoz

      • Head Commercial Operations EUMEA at Sandoz

      • President and CEO of Sandoz US

    • President and Secretary of the European Generic medicines Association (EGA)

    • Extensive experience in Generics (EU and US), Marketing & Sales and Portfolio Management

    • M.Sc. degree in Clinical Chemistry

  • Andreas Premstaller Ph.D., Partner

    • Lead: "Over 25 years of leadership experience in the development, manufacturing, and supply of biopharmaceutical, biosimilars and cell therapy products, from early-stage research through clinical development to commercial supply. Key strengths include:"

      • Built and led strong cross-functional teams

      • Drove regulatory and quality strategies to achieve regulatory approvals for commercial and clinical programs

      • Executed complex investment and organizational transformation initiatives

      • Skilled in site and GMP operations, capacity expansions, regulatory interactions and operational excellence

    • Ph.D. in Chemistry


  • Dorothea Ledergerber Ph.D., Associate Partner

    Ph.D., Associate Partner
    • Over 25 years of international leadership experience across research, technical development (CMC) and global manufacturing of drug products, spanning small molecules, biologics and advanced therapies. Senior positions included:

      • Multi Site Head of Drug Product Operations at Siegfried

      • Chief Technical Officer at Tigen Pharma

      • Executive Project Director at Novartis

      • Led the scale-up and industrialisation of cell & gene therapy programs from funding approval to commercial readiness

      • Extensive experience bridging scientific innovation, industrial execution and commercial opportunity